Literature DB >> 24371556

Identification of a mechanism for lung inflammation caused by Mycoplasma pneumoniae using a novel mouse model.

Takeshi Saraya1, Koh Nakata2, Kazuhide Nakagaki3, Natsuki Motoi2, Kuniko Iihara4, Yasunori Fujioka5, Teruaki Oka6, Daisuke Kurai1, Hiroo Wada1, Haruyuki Ishii1, Haruhiko Taguchi7, Shigeru Kamiya8, Hajime Goto1.   

Abstract

Human Mycoplasma pneumoniae (MP) pneumonia is characterized by alveolar infiltration with neutrophils and lymphocytes and lymphocyte/plasma cell infiltrates in the peri-bronchovascular area (PBVA). No mouse model has been able to mimic the pathological features seen in human MP pneumonia, such as plasma cell-rich lymphocytic infiltration in PBVA. To figure out the mechanism for inflammation by MP infection using a novel mouse model that mimics human MP pneumonia, mice were pre-immunized intraperitoneally with Th2 stimulating adjuvant, alum, alone or MP extracts with an alum, followed by intratracheal challenge with MP extracts. The toll-like receptor-2, which is the major receptor for mycoplasma cell wall lipoproteins, was strongly up-regulated in alveolar macrophages in a latter group after the pre-immunization but prior to the intratracheal challenge. Those findings demonstrated that acceleration of innate immunity by antecedent antigenic stimulation can be an important positive-feedback mechanism in lung inflammation during MP pneumonia.

Entities:  

Keywords:  AMs, alveolar macrophage; Alveolar macrophage; BAL, bronchoalveolar lavage; IT, intratracheal challenge; MP pneumonia, Mycoplasma pneumonia; MP, Mycoplasma pneumoniae; Mice model; Mycoplasma pneumonia extracts; Mycoplasma pneumoniae pneumonia; PBA, peribronchiolare area; PBVA, peri-bronchovascular area; PVA, perivascular area; Plasma cell; TLR, Toll-like receptor; Toll-like receptor-2

Year:  2011        PMID: 24371556      PMCID: PMC3850488          DOI: 10.1016/j.rinim.2011.11.001

Source DB:  PubMed          Journal:  Results Immunol        ISSN: 2211-2839


  55 in total

1.  Primary atypical pneumonia; report of eight cases with autopsies.

Authors:  F PARKER; L S JOLLIFFE; M FINLAND
Journal:  Arch Pathol (Chic)       Date:  1947-12

2.  Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids.

Authors:  C Stellato; L A Beck; G A Gorgone; D Proud; T J Schall; S J Ono; L M Lichtenstein; R P Schleimer
Journal:  J Immunol       Date:  1995-07-01       Impact factor: 5.422

3.  Immunoglobulin-containing cells in lungs of hamsters infected with Mycoplasma pneumoniae.

Authors:  G W Fernald; W A Clyde; J Bienenstock
Journal:  J Immunol       Date:  1972-05       Impact factor: 5.422

4.  Fatal infections associated with Mycoplasma pneumoniae: discussion of three cases with necropsy findings.

Authors:  B R Meyers; S Z Hirschman
Journal:  Mt Sinai J Med       Date:  1972 May-Jun

5.  A dipalmitoylated lipoprotein from Mycoplasma pneumoniae activates NF-kappa B through TLR1, TLR2, and TLR6.

Authors:  Takashi Shimizu; Yutaka Kida; Koichi Kuwano
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

6.  Mycoplasma fermentans (incognitus strain) cells are able to fuse with T lymphocytes.

Authors:  D S Dimitrov; G Franzoso; M Salman; R Blumenthal; M Tarshis; M F Barile; S Rottem
Journal:  Clin Infect Dis       Date:  1993-08       Impact factor: 9.079

7.  Hamster challenge potency assay for evaluation of Mycoplasma pneumoniae vaccines.

Authors:  M F Barile; D K Chandler; H Yoshida; M W Grabowski; S Razin
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

8.  Inhaled fluticasone propionate reduces concentration of Mycoplasma pneumoniae, inflammation, and bronchial hyperresponsiveness in lungs of mice.

Authors:  Hong Wei Chu; Jennifer A Campbell; John G Rino; Ronald J Harbeck; Richard J Martin
Journal:  J Infect Dis       Date:  2004-03-02       Impact factor: 5.226

Review 9.  Mycoplasma pneumoniae-associated bronchiolitis causing severe restrictive lung disease in adults: report of three cases and literature review.

Authors:  E D Chan; T Kalayanamit; D A Lynch; R Tuder; P Arndt; R Winn; M I Schwarz
Journal:  Chest       Date:  1999-04       Impact factor: 9.410

View more
  9 in total

1.  Mycoplasma pneumoniae extract induces an IL-17-associated inflammatory reaction in murine lung: implication for mycoplasmal pneumonia.

Authors:  Daisuke Kurai; Kazuhide Nakagaki; Hiroo Wada; Takeshi Saraya; Shigeru Kamiya; Yasunori Fujioka; Koh Nakata; Hajime Takizawa; Hajime Goto
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

Review 2.  Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications.

Authors:  Takeshi Saraya; Daisuke Kurai; Kazuhide Nakagaki; Yoshiko Sasaki; Shoichi Niwa; Hiroyuki Tsukagoshi; Hiroki Nunokawa; Kosuke Ohkuma; Naoki Tsujimoto; Susumu Hirao; Hiroo Wada; Haruyuki Ishii; Koh Nakata; Hirokazu Kimura; Kunihisa Kozawa; Hajime Takizawa; Hajime Goto
Journal:  Front Microbiol       Date:  2014-08-11       Impact factor: 5.640

Review 3.  Correlation between Radiological and Pathological Findings in Patients with Mycoplasma pneumoniae Pneumonia.

Authors:  Hiroshi Tanaka
Journal:  Front Microbiol       Date:  2016-05-11       Impact factor: 5.640

4.  The Correlation between Chest X-ray Scores and the Clinical Findings in Children and Adults with Mycoplasma pneumoniae Pneumonia.

Authors:  Takeshi Saraya; Takayasu Watanabe; Yayoi Tsukahara; Kosuke Ohkuma; Haruyuki Ishii; Hirokazu Kimura; Kunimasa Yan; Hajime Goto; Hajime Takizawa
Journal:  Intern Med       Date:  2017-09-25       Impact factor: 1.271

Review 5.  Mycoplasma pneumoniae infection: Basics.

Authors:  Takeshi Saraya
Journal:  J Gen Fam Med       Date:  2017-04-17

Review 6.  A Compendium for Mycoplasma pneumoniae.

Authors:  Gretchen L Parrott; Takeshi Kinjo; Jiro Fujita
Journal:  Front Microbiol       Date:  2016-04-12       Impact factor: 5.640

7.  Ameliorative Effects of Infantile Feire Kechuan Oral Solution on Mycoplasma Pneumoniae Pneumonia in Infant Mouse and Rat Models.

Authors:  Shanshan Guo; Lei Bao; Tiange Qu; Xin Mao; Yingjie Gao; Yingli Xu; Xiaolan Cui
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-17       Impact factor: 2.629

8.  Assessment of serum sialic acid correlated with C3 in children with Mycoplasma pneumoniae pneumonia.

Authors:  Yu-Mei Mi; Qi Qi; Li Zhang; Xiao-Fang Wang; Zhi-Min Chen; Chun-Zhen Hua
Journal:  J Clin Lab Anal       Date:  2020-01-06       Impact factor: 2.352

9.  Current perspectives on atypical pneumonia in children.

Authors:  Jung Yeon Shim
Journal:  Clin Exp Pediatr       Date:  2020-06-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.